Catalyst
Slingshot members are tracking this event:
CHMP Recommends Approval of Bristol-Myers Squibb's (BMY) Opdivo as Single Agent for Squamous Cell Cancer of the Head and Neck After Platinum-Based Chemotherapy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BMY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 24, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Chmp, Opdivo, Squamous Cell Cancer, Head And Neck Cancer, Platinum-based Chemotherapy, European Medicines Agency
